Impact of Psychiatric Genetic Data on Civil Litigation and its Relationship with Stigma

精神病学基因数据对民事诉讼的影响及其与耻辱的关系

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Advances in psychiatric genetics are likely to offer major diagnostic and therapeutic benefits, but also legal and social-related risks, to individuals who were diagnosed with, or have a proclivity for, psychiatric disorders. In response, courts and policy-makers will have to ensure that psychiatric genetic data are used to promote, and not to obstruct, equality, justice, and social inclusion. However, few studies have queried how such data might impact judicial decision-making; none have explored this question in civil proceedings about parental rights, children's education, and responsibility for behavior in tort. This K01 proposes to study the impact of psychiatric genetic data on these 3 prominent areas of litigation and its relationship to stigma to better understand the implications of new discoveries in psychiatric genetics for law, society, and individual rights, and to inform policy-makers about this knowledge as they devise responses to these advances. The study's aims are: 1) To survey appellate court decisions in family law, education, and torts to determine the extent to which courts are considering psychiatric genetic data, and how they use such data in their decisions; 2) To investigate judicial views about the use of psychiatric genetic data and how such data may affect judges' and public perceptions of parental capacity, educational decisions, and civil responsibility for behavior in tort cases; and 3) To assess the association between psychiatric genetic data and stigma by studying if such data affect judges' and public perception of broader civil legal incapacity and treatment options, and the relationship to judicial bias against persons with psychiatric conditions. For Aim 1, I will use a mix of qualitative legal analysis and empirica methods. For Aim 2, I will use a vignette methodology, administered in 3 waves, with samples, respectively, of family court judges, parents, and state trial court judges and the jury-eligible general population. For Aim 3, I will use existing legal and sociological literature on psychiatric related stigma to develop measures of explicit stigma, and a computer-based measure designed to detect implicit bias, administered as part of the vignettes, to assess the relationships among psychiatric genetic data, judicial decisions, and stigma. Findings will be published in peer-reviewed medical, psychological and policy journals. Complementing these studies will be an intensive training program comprised of didactic courses, tailored training, clinical exposure at the NY State Psychiatric Institute, and mentored experience. My primary mentor Dr. Appelbaum, co-mentors Drs. Link and Ottman, collaborator, Dr. Phelan, biostatistician, Dr. Goldsmith, and consultant, Dr. Parens will train and monitor my progress as I attain my training goals to: 1) develop the skills necessary for conducting empirical research; 2) learn about the clinical aspects of psychiatric disorders; and 3) build and expand national and international professional collaborations with scholars in psychiatry, genetics, social sciences, bioethics, and law. This training will culminate in R01 grant submission to further study the intended and unintended consequences of psychiatric genetic data on law, equality, and social inclusion.
 描述(由申请人提供):精神病遗传学的进展可能会提供主要的诊断和治疗益处,但也有法律的和社会相关的风险,个人谁被诊断为,或有倾向,精神疾病。作为回应,法院和政策制定者必须确保精神病遗传数据用于促进而不是阻碍平等,正义和社会包容。然而,很少有研究质疑这些数据如何影响司法决策;没有人在民事诉讼中探讨这个问题,如父母权利、子女教育和侵权行为责任。K 01建议研究精神病遗传数据对这三个突出的诉讼领域的影响及其与耻辱的关系,以更好地了解精神病遗传学新发现对法律,社会和个人权利的影响,并在制定应对这些进步的措施时告知政策制定者这些知识。这项研究的目的是:1)调查上诉法院在家庭法、教育和侵权方面的判决,以确定法院在多大程度上考虑精神病遗传数据,以及他们如何在判决中使用这些数据; 2)调查关于使用精神病遗传数据的司法观点,以及这些数据如何影响法官和公众对父母能力、教育决定和侵权案件中行为的民事责任的看法;通过研究精神病遗传数据是否影响法官和公众对更广泛的民事法律的无行为能力和治疗方案的看法,以及与司法偏见的关系,评估精神病遗传数据与污名化之间的关联 有精神病的人对于目标1,我将混合使用定性法律的分析和分析方法。对于目标2,我将使用一个小插曲的方法,管理在3波,样本,分别是家庭法院法官,父母,和州初审法院法官和陪审团合格的一般人群。对于目标3,我将使用现有的法律的和社会学文献,对精神病 相关的耻辱,以制定明确的耻辱的措施,和一个基于计算机的措施,旨在检测隐含的偏见,管理的一部分,小插曲,精神病遗传数据,司法判决,和耻辱之间的关系进行评估。研究结果将发表在同行评审的医学、心理学和政策期刊上。补充这些研究将是一个密集的培训计划,包括教学课程,量身定制的培训,在纽约州精神病研究所的临床暴露,并指导经验。我的主要导师Appelbaum博士、共同导师Link博士和合作者Alberman博士、生物统计学家金匠博士和顾问Parens博士将对我进行培训并监督我的进展,因为我实现了以下培训目标:1)发展进行实证研究所需的技能; 2)了解精神疾病的临床方面; 3)与精神病学、遗传学、社会科学、生物伦理学和法律领域的学者建立和扩大国家和国际专业合作。这项培训将最终在R 01赠款提交进一步研究精神病遗传数据对法律,平等和社会包容的预期和意外后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maya Sabatello其他文献

Maya Sabatello的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maya Sabatello', 18)}}的其他基金

Disability, diversity and trust in precision medicine research: stakeholdersengagement
精准医学研究中的残疾、多样性和信任:利益相关者参与
  • 批准号:
    10259657
  • 财政年份:
    2021
  • 资助金额:
    $ 17.39万
  • 项目类别:
Blind/Disability and Intersectional Biases in E-Health Records (EHRs) of Diabetes Patients: Building a Dialogue on Equity of AI/ML Models in Clinical Care
糖尿病患者电子健康记录 (EHR) 中的盲/残疾和交叉偏差:建立关于临床护理中 AI/ML 模型公平性的对话
  • 批准号:
    10599633
  • 财政年份:
    2021
  • 资助金额:
    $ 17.39万
  • 项目类别:
Disability, diversity and trust in precision medicine research: stakeholdersengagement
精准医学研究中的残疾、多样性和信任:利益相关者参与
  • 批准号:
    10653189
  • 财政年份:
    2021
  • 资助金额:
    $ 17.39万
  • 项目类别:
Disability, diversity and trust in precision medicine research: stakeholdersengagement
精准医学研究中的残疾、多样性和信任:利益相关者参与
  • 批准号:
    10370875
  • 财政年份:
    2021
  • 资助金额:
    $ 17.39万
  • 项目类别:
Disability, diversity and trust in precision medicine research: stakeholdersengagement
精准医学研究中的残疾、多样性和信任:利益相关者参与
  • 批准号:
    10477382
  • 财政年份:
    2021
  • 资助金额:
    $ 17.39万
  • 项目类别:
Impact of Psychiatric Genetic Data on Civil Litigation and its Relationship with Stigma
精神病学基因数据对民事诉讼的影响及其与耻辱的关系
  • 批准号:
    9330895
  • 财政年份:
    2015
  • 资助金额:
    $ 17.39万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 17.39万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 17.39万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 17.39万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 17.39万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 17.39万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 17.39万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 17.39万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 17.39万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 17.39万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 17.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了